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Purpose: Febrile seizures (FS) are seizures that occur between the age of 6 and 60 months, but its 
pathophysiology still is not fully understood. There is limited information about the correlation between levels 
of selenium and leptin with FS. This study aimed to determine the relationship between serum levels of 
selenium and leptin in children with FS.
Methods: This case-control study was conducted in a University Hospital in Shahrekord, Iran, in 
2011. The serum levels of selenium and leptin of 25 children with simple febrile seizure (case group) 
were compared with 25 febrile children without seizure (control group) in acute phase and after 
three months. The levels of serum selenium and leptin were measured by flame atomic absorption 
spectrophotometer and enzyme-linked immunosorbent assay method, respectively. 
Results: In acute phase, the mean serum level of selenium in case and control groups were 95.88± 
42.55 and 113.25±54.43 μg/dL, respectively, and difference was not significant (P=0.415), but after 
three months, this level had a significant increase in both groups (P<0.001). In acute phase, the mean 
serum leptin level in case and control groups were 0.94±0.5 and 0.98±0.84 ng/mL, respectively, 
but difference was not significant (P=0.405). After three months, serum leptin level had no significant 
change in both groups (P=0.882).
Conclusion: These observations suggest that serum levels of selenium and leptin have not specific 
relation with FS but overllay is lower, however, further study is recommended. Also selenium level in 
stress and acute phase was significantly lower than recovery phase. 
Key words: Febrile seizures, Leptin, Selenium
Corresponding author: Neda Parvin, MSc
Department of Nursing, Shahrekord University of 
Medical Sciences, Shahrekord, Iran
Tel: +98-381-333-5648
Fax: +98-381-333-5648
E-mail: np285@yahoo.com
Received: 30 May 2012
Revised: 11 September 2012
Accepted: 25 October 2012
Copyright © 2013 by The Korean Pediatric Society
This is an open-access article distributed under the 
terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/
licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any 
medium, provided the original work is properly cited.
Original article
Korean J Pediatr 2013;56(2):80-85
http://dx.doi.org/10.3345/kjp.2013.56.2.80
eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr
Introduction
Febrile seizures (FS) are seizures that occur between the age of 6 and 60 months with a 
temperature of 38°C or higher, that are not the result of central nervous system infection 
or any metabolic imbalance, and that occur in the absence of a history of prior afebrile 
seizures1). The incidence of FS is between 2% to 5%2).  Although febrile seizure is the most 
common form of seizures in children3), its pathophysiology still is not fully understood4). 
Risk factors for FS include genetic factors, micronutrient deficiency e.g., iron, zinc3,5,6), and 
immunologic reactions7).
It is about one century since the addition of selenium to the periodic table of elements. 
After 1973 when Rotruck et al.8) revealed the role of selenium in a detoxi fying enzyme, 
glutathione peroxidase, this element has been demonstrated to have a positive biological 
function in various aspects of human health. Selenium is an important micronutrient that 
has antioxidant effects in cells, especially in brain cells9,10). Also studies have shown that 
seizures may result in free radical production and oxidative damage11). 
Mahyar et al.12) and Amiri et al.13) showed that the serum selenium level in the children 
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who had simple FS was signifi cantly lower than in the non-
seizure control group.
Leptin, a 16 kDa neurohormone predominantly synthesized 
and released into blood by adipocytes, has an important role in 
regulating body weight and has receptors on neurons outside the 
hypothalamus and modulates their excitability acutely. Leptin 
modulation of neuronal excitability outside the hypothalamus 
is potentially important if blood leptin can access its receptors 
on these neurons. Leptin transporters throughout the brain give 
leptin access to its receptors on hippocampal and other cortical 
neurons14). 
The increased serum leptin in rats fed a ketogenic diet fur-
ther implicates leptin as an endogenous modulator of neuronal 
excitability because the ketogenic diet is an effective treatment 
for intractable epilepsy15,16). This observation suggests that 
chronically elevated blood leptin levels decrease neuronal 
excitability17).
In contrast to the anticonvulsant effects that have been re-
ported for leptin in some nonclinical studies, a number of inve-
stigators have described opposite findings: i.e., proconvulsant 
and convulsant-related activity. For ex ample, leptin application 
was found to be neuroexcitatory in that it enhanced N-methyl-D-
aspartic acid (NMDA) receptor-mediated increases in intracellular 
Ca2+ levels and synaptic transmission in rat hippocampal 
cell cultures and brain slices18). Using electrophysiological 
recordings from proopiomelanocortin type neurons of mice, 
it was demonstrated that leptin increased the frequency of 
action potentials19). In dissociated cerebellar granule cells, leptin 
augmented Ca2+ influx following activation of NMDA recep tors20). 
Additionally, in vivo administration of leptin to rats enhanced the 
rate of penicillin induced epilepti form activity, thus leading the 
investigators to speculate that leptin could have proconvulsant 
activity21). So a num ber of other nonhuman experiments have 
demonstrated proconvulsant activity for leptin22). A possible role 
of selenium and leptin in provoking FS has been reported in a 
few studies 12,13), but it is still questionable whether selenium and 
leptin play any role in the provoking of FS. The present study was 
designed to determine the correlation between serum levels of 
selenium and leptin and FS.
Materials and methods
This case-control study was conducted at the hospital of the 
University of Shahrekord, Iran. The study was approved by the 
Ethical Committee of the Research Department in the Shahrekord 
University of Medical Sciences before data were collected. 
For this study, we enrolled 25 children who were clinically 
diagnosed with FS. All FS patients met stringent FS criteria 
based on those used by Freeman23). Twenty-five febrile children 
without seizure for controls were recruited from febrile patients 
who were admitted to pediatric department for non-FS diseases 
such as pneumonia or acute gastroenteritis. The case and control 
were selected consecutively from children admitted to the 
hospital, based on their symptoms. Inclusion criteria for the case 
group were age between 6 to 60 months; simple febrile seizure; 
absence of central nervous system infection; and absence of 
electrolyte imbalance. Children with complex FS, no febrile 
seizure, epilepsy, and neurologic deficit were excluded. 
For each patient, the following information was obtained: 
complete medical history and clinical examination with special 
emphasis on age, sex, type and frequency of seizure and duration 
of illness. Inclusion criteria for the control group were fever 
without a history of seizure, admitted to hospital because of mild 
infection, and no intervention for their problem. Children in both 
groups were matched in terms of age, sex, weight, height, head 
circumference, and fever severity. 
Weight, height, head circumference, and body temperature 
(axillary) were measured according to standard methods. None 
of the individuals showed any digestive symptoms indicative of 
nutrient malabsorption. All parents of the children were given 
information about the research method in a simple language and 
had signed the written informed consent form.
The serum levels of selenium and leptin of twenty-five 
children with simple FS (case group) were compared with 
twenty-five febrile children without any history of FS (control 
group) in acute phase (at least 12 hours after admission) and 
recovery phase (after three months). The study was conducted 
from 2010 to 2011. 
Blood samples were taken between 9 AM and 11 AM. In 
the case group, the blood sample was taken at least 12 hours 
after treating the seizure. In the both groups, 6 mL blood from 
the peripheral vessels was taken and centrifuged. The clean 
serum was then poured into an acid-washed tube and stored 
at -70°C in the refrigerator until the time of analysis. Selenium 
concentration was determined using hydride generation atomic 
absorption spectrometry. Measurement of serum selenium 
was done by an atomic flame spectrophotometer method. 
The flame spectrophotometer machine was an Australian-
made Varian Spectra AA220 model. To improve accuracy, all 
measurements of serum selenium were rechecked. The normal 
range of serum selenium level is 46–143 μg/dL24). Leptin was 
detected with commercially available test kits were used to 
measure leptin (enzyme-linked immunosorbent assay [ELISA] 
method, DRG International, Mountainside, NJ, USA), which 
has a range of 0.25–120 ng/mL. The DRG Leptin ELISA is an 
enzyme immunoassay for the measurement of leptin in serum 
and plasma. In the DRG Leptin ELISA the following values are 
observed: males 3.84±1.79 ng/mL, females 7.36±3.73 ng/mL25).
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1. Statistical analysis
Data are shown as mean±standard deviation. All statistical 
analyses were performed using the IBM SPSS ver. 18.0 (IBM Co., 
Armonk, NY, USA). In addition, Mann-Whitney, Wilcoxon, and 
chi-square tests were used to compare the variables between the 
both case and control groups. A value of P<0.05 was considered 
significant.
Results
This study enrolled twenty-five Iranian patients who had been 
clinically diagnosed with FS and twenty-five febrile children 
without any history of FS. The average ages of the FS and 
control patients, were 24.8±13.7 months, and 24.5±13.9 months, 
respectively and there was no statistically significant difference 
between the groups (P=0.8). In the case group, 18 (72%) were 
male and 7 (28%) were female; in the control group, 21 (84%) 
were male and 4 (16%) were female and there was no statistically 
significant difference between the groups (P=0.3).
The average body mass index of the FS and control patients, 
were 17.46±2.63 and 16.37±1.97, respectively and there was no 
statistically significant difference between the groups (P=0.1).
In acute phase, minimum and maximum level of serum 
selenium in the case group was 18.4 and 186.2 μg/dL, respectively, 
compared with 47.44 and 240.54 μg/dL in the control group. In 
this time, minimum and maximum level of serum leptin in the 
case group was 0.4 and 2.2 ng/mL, re spectively, compared with 0.3 
and 3.5 ng/mL in the control group.
After three months, minimum and maximum level of serum 
selenium in the case group was 99.14 and 277.54 μg/dL, 
respectively, compared with 68.24 and 496.24 μg/dL in the control 
group. In this time, minimum and maximum level of serum leptin 
in the case group was 0.4 and 2.1 ng/mL, respectively, compared 
with 0.3 and 1.7 ng/mL in the control group.
The mean selenium and leptin levels in case group were 
95.88±4.25 μg/dL and 0.94±0.5 ng/mL respectively, and in 
con trol group, were 113.25±5.44 μg/dL and 0.98±0.84 ng/
mL, respectively. Mann-Whitney test showed no significant 
differences in the levels of selenium and leptin between patients 
in case and control groups, although patients with FS had lower 
levels of selenium and leptin than the control group (P>0.05). 
After three months, Wilcoxon U test showed selenium level had 
a significant increase in both groups (P< 0.001), but leptin level 
had not significant change in both groups (P=0.882) (Table 1).
Twenty-one of the twenty five FS patients (84%) had only one 
FS attacks by the time of our study.
Discussion
Febrile seizure is the most common brain-related disease in 
children3). Several studies have indicated that multiple factors 
can be involved in the pathogenesis of FS. This study was 
designed to address whether selenium and leptin have any role 
in developing FS. 
Oxidative stress and production of reactive oxygen and nitro-
gen species are some of the etiologies of epilepsy26-28). Selenium 
was used in management a number of the neurologic disorders 
including epilepsy in some studies29,30). Selenium has antioxidant 
properties; it prevents cell bodies from oxidation and keeps them 
biologically healthy31). 
Although the correlation between selenium deficiency and 
epilepsy has been shown in several studies32,33), the pathogenesis 
involvement of selenium in FS has not been completely re-
cognized.
Simple FS are generally considered as benign phenomenon, 
with tendency to develop epilepsy, especially the temporal form 
of seizure following a prolonged seizure34).
Although the pathophysiology of FS is still unknown1,13,16), 
several studies have indicated that multiple factors can be 
involved in the pathogenesis of FS, including genetic factors3) 
interleukin-1β35), iron36), and zinc37,38).
It is known that oxidative stress and generation of reactive 
oxygen species are a cause and consequence of epileptic sei-
zures. It has been suggested that some antiepileptic drug 
therapies such as valproic acid, deplete the total body selenium 
level and selenium-dependent glutathione peroxidase (GSH-Px) 
activity although therapy with a new epileptic drug, topiramate, 
activated GSH-Px activity in epileptic animals and humans. 
Selenium is incorporated into an interesting class of molecules 
known as selenoproteins that contain the modified amino acid, 
selenocysteine. There are signs of selenium and selenoprotein 
deficiency in the pathogenesis of epilepsy39).
In summary, there is convincing evidence for the proposed 
crucial role of selenium and deficiency of GSH-Px enzyme acti-
vity in epilepsy pathogenesis40).
Table 1. Serum selenium and leptin levels in the case and control 
groups in the acute and recovery phases (After 3 Months)
Group Time of check Case Control P  value
Serum selenium 
(μg/dL)
Acute phase 113.25±54.43 95.88±42.55 0.415
Recovery phase 177.67±82.07 158.88±38.9 0.332
Serum leptin 
(ng/mL) 
Acute phase 0.98±0.84 0.94±0.5 0.405
Recovery phase 0.82±0.37 0.94±0.45 0.32
Values are presented as mean±standard deviation.
There was not statistically significant difference between the two groups in 
serum selenium and leptin levels (P>0.05).
There was significant increase in selenium level after three months in both 
groups (P<0.001)
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Mahyar et al.12) and Amiri et al.13) found that serum selenium 
level in the children with febrile seizure was  significantly lower 
than that in healthy children, but in the recent study there was 
no significant difference in serum selenium level in the children 
with FS and  non-FS children and  there was no significant 
difference between genders. Serum selenium level in this 
study was similar to Safaralizadeh et al.40) re search in Tehran, 
but higher than Mahyar et al.12) and Amiri et al.13). Difference 
between these studies probably related to geographical difference 
in intake of selenium in different regions. There is no integrated 
study in Iran about selenium level in different geographic areas, 
but results of present study revealed that selenium level in 
Shahrekord (South West Iran) may be higher than Qazvin and 
Tehran12,13). 
In present study selenium level was assessed in two stages: 
acute and recovery phase, and in both stage, the average 
level was higher than Mahyar et al.12) and Amiri et al.13) study. 
Differences in selenium level related to several factors such as 
selenium content of soil, dietary habits and the geographical 
variation of selenium intake41). In some regions of the world such 
as Finland, New Zealand, the East Coast of the United States of 
America, and China the content of selenium in soil is remarkably 
low42). Therefore selenium levels in the serum of populations 
throughout the world are different. There is currently no infor-
mation of selenium intake and serum levels in the Iranian 
population, so difference in serum selenium levels in Iranian 
study may be related to content of selenium in soil.
Similar to Sammalkorpi et al.43), Srinivas et al.44), and Olmez et 
al.45) findings, after three months, in recovery period, selenium 
level had a significant increase in both groups of study. Sel-
enium, as an essential micronutrient, is required for the proper 
functioning of the immune system and its deficiency affects 
the occurrence, virulence, or disease progression of some viral 
infections. Sammalkorpi et al.43) concluded that acute infections 
decrease serum levels regardless of the infective agent, because 
of the possible connection between selenium and the immune 
system.
Measurement of micronutrient levels in the presence of in-
flammation is difficult for several reasons. Changes in levels of 
acute phase proteins are associated with increased plasma levels 
of some indicators of micronutrient status, such as ferritin, and 
decrease of others, such as retinol. Alterations in the plasma 
levels of acute phase proteins can occur from hemodilution, 
sequestration and increased or decreased rates of synthesis and 
breakdown. How much these relate to functional deficiency is 
not known46). In other hand, selenium level as a micronutrient, is 
often measured directly in serum, plasma, whole blood and hair. 
It has also been measured indirectly by assays of plasma GSH-
Px levels47). Both serum and whole blood levels are decreased 
during the acute phase response. Low levels occur in several 
infections43,48). Several viral infections appear to stimulate the 
production of selenoproteins, leading to low serum levels of 
selenium. Patients with the lowest levels of selenium have the 
highest levels of morbidity and mortality but a causal effect has 
not yet been demonstrated49). Overall it is noted that selenium 
levels are low in infection. It is due to the consumption of 
selenium as an antioxidant as part of the process of quenching 
free radicals50). Whether plasma selenium is also reduced as part 
of the inflammatory process has not been studied intensively 
and there are no published attempts to control for changes in 
selenium due to changes in inflammatory proteins.
Additionally, the mean leptin value in case and control group 
at baseline of recent study was 0.94±0.5 and 0.98±0.84 ng/mL, 
respectively. Although patients with FS had not significant lower 
levels of leptin than the control group, after three months, leptin 
level had not significant change in two groups.
To our knowledge, however, there have been no similar studies 
establishing the correlation between serum leptin level and FS. 
Leptin has been proposed for clinical use as an anticonvulsant 
in addition to its potential metabolic effects in humans51-53). 
Support for such an indication has come from both in vitro and 
animal study data. For example, Glaum et al.54) demonstrated 
that leptin treatment reduced evoked glutamatergic excitatory 
postsynaptic current (an antiexcitatory effect) in rat brain 
slices but had no effects on GABAergic inhibitory postsynaptic 
current. In rat hippocampal brain cell cultures and slices, leptin 
exposure decreased evoked epileptiform-like activity52,55). Fur-
thermore, an in vivo study demonstrated that leptin inhi-
bited 4-aminopyridine-induced convulsions in rats and pen-
tylenetetrazole-induc ed convulsions in mice, and another study 
showed that pentylenetetrazole-induced convulsions were less 
severe in wild-type mice than in leptin-deficient mice53,56).
Evaluation of leptin levels in response to experimental models 
of inflammation in rats revealed elevated plasma concen-
trations57). Leptin was also shown to be involved in the early 
(<24 hour) acute phase response after moderately severe surgical 
trauma58), and to play a role in acute sepsis59). Its significant 
correlation with other acute-phase proteins indicates that 
leptin could be a participant in acute-phase protein synthesis 
regulation during a systemic inflammatory response60).
In contrast to the anticonvulsant effects that have been 
reported for leptin in some nonclinical studies, a number 
of investigators have described opposite findings: i.e., pro-
con vulsant and convulsant-related activity. For example, 
leptin application was found to be neuroexcitatory in that it 
enhanced NMDA receptor-mediated increases in intracellular 
Ca2+ levels and synaptic transmission in rat hippocampal cell 
cultures and brain slices18). Using electrophysiological re-
cordings from proopiomelanocortin type neurons of mice, it 
was demonstrated that leptin increased the frequency of action 
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potentials57). Additionally, in vivo administration of leptin to rats 
enhanced the rate of penicillin-induced epileptiform activity, 
thus leading the investigators to speculate that leptin could have 
proconvulsant activity26). 
In summary, results of the present study indicate that, the 
serum selenium and leptin levels of children with simple FS 
were not significantly lower than that of febrile children without 
seizure and other factors may be involved. In addition, studies 
with larger samples are recommended to further examine the 
correlation between FS and the levels of serum selenium and 
leptin.
Limitations to the present study (low budget and low sample 
size) influence the generalizability of the results. Further research 
with larger samples and healthy control group is warranted to 
identify the correlation of selenium and leptin with FS.
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